Thr824

Site Information
VRDNIQLtPEAEEDI SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 3727709
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 )
Disease tissue studied:	lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 2 ) , non-small cell lung adenocarcinoma ( 2 ) , small-cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	DMS153 (pulmonary) ( 2 ) , DMS53 (pulmonary) ( 1 ) , HeLa (cervical) ( 5 ) , Jurkat (T lymphocyte) ( 3 , 4 ) , lung ( 1 , 2 ) , NCI-H1437 (pulmonary) ( 2 ) , NCI-H2073 (pulmonary) ( 2 ) , NCI-H209 (pulmonary) ( 2 ) , NCI-H446 (pulmonary) ( 1 ) , NCI-H526 (pulmonary) ( 1 ) , NCI-H69 (pulmonary) ( 1 ) , NCI-H82 (pulmonary) ( 1 ) , NCI-H838 (pulmonary) ( 2 )

References
1	Rikova K, Hall B (2013) CST Curation Set: 20735, 21162, 30155, 30156, 30157; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
2	Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
3	Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7 23749302 Curated Info
4	Possemato A (2009) CST Curation Set: 6922; Year: 2009; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P Curated Info
5	Chen RQ, et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 69, 2663-8 19276368 Curated Info